Also trades as: 3613.HK (HKSE) · $vol 1M
BJTRF OTC
Beijing Tong Ren Tang Chinese Medicine Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.1%
5Y: -46.0%
$0.65
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$599M
+2.0% ▲
5Y CAGR: +6.2%
Total Liabilities
$37M
-6.9% ▼
5Y CAGR: -1.1%
Shareholders Equity
$538M
+2.6% ▲
5Y CAGR: +6.7%
Cash & Investments
$293M
+24.1% ▲
5Y CAGR: +4.2%
Total Debt
$16M
+2.3% ▲
5Y CAGR: +3.5%
Net Debt
-$270M
+83.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $213M | $255M | $128M | $228M | $286M |
| Short-Term Investments | $79M | $32M | $179M | $47M | $7M |
| Cash & ST Investments | $292M | $287M | $307M | $236M | $293M |
| Net Receivables | $68M | $121M | $423M | $68M | $54M |
| Inventory | $55M | $60M | $130M | $204M | $172M |
| Other Current Assets | $4M | $2M | -$369M | -$140K | $1M |
| Total Current Assets | $420M | $471M | $492M | $510M | $522M |
| Property, Plant & Equip. | $53M | $52M | $437M | $429M | $58M |
| Goodwill & Intangibles | $14M | $14M | $56M | $9M | $8M |
| Long-Term Investments | $8M | $8M | $8M | -$33M | $6M |
| Other Non-Current Assets | -$6M | -$6M | $52M | $154M | $0 |
| Total Non-Current Assets | $75M | $72M | $590M | $594M | $77M |
| Total Assets | $495M | $543M | $568M | $587M | $599M |
| — Liabilities — | |||||
| Accounts Payable | $35M | $154M | $177M | $5M | $8M |
| Short-Term Debt | $62K | $28K | $21K | $9K | $7M |
| Deferred Revenue | $578K | $599K | $0 | $0 | $495K |
| Other Current Liabilities | -$58M | -$257M | $12M | $169M | $8M |
| Total Current Liabilities | $27M | $54M | $42M | $235M | $27M |
| Long-Term Debt | $102K | $43K | $21K | $18K | $9K |
| Other Non-Current Liab. | $0 | $0 | $0 | $397K | $463K |
| Total Non-Current Liabilities | $14M | $11M | $11M | $10M | $11M |
| Total Liabilities | $41M | $65M | $53M | $40M | $37M |
| — Equity — | |||||
| Common Stock | $120M | $120M | $120M | $121M | $121M |
| Retained Earnings | $319M | $345M | $381M | $411M | $424M |
| Accumulated OCI | -$2M | -$4M | -$4M | $0 | $0 |
| Total Stockholders Equity | $438M | $461M | $495M | $524M | $538M |
| Total Liabilities & Equity | $495M | $543M | $568M | $587M | $599M |
| — Key Metrics — | |||||
| Total Debt | $16M | $13M | $17M | $16M | $16M |
| Net Debt | -$196M | -$242M | -$111M | -$1.6B | -$270M |
| Total Investments | $87M | $40M | $187M | $14M | $13M |